Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Universities, institutes and hospitals at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
26 universities, institutes and hospitals are at Biomarkers Europe 2026 — 36 presentations on the program. Most represented: UMC Utrecht (2 on the program), European Institute of Oncology (IEO) (1 on the program), Barts Cancer Institute, Queen Mary University of London (1 on the program). 9 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–16 of 26 organizations
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
UMC Utrecht Utrecht, Netherlands | |
University medical center in Utrecht combining patient care, research and teaching. | Talk Tue Oct 13 12:15pm–12:40pm AI Supported Histopathology - Implementation & Validation Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Talk Tue Oct 13 5:35pm–6:00pm Decoding Tumor Histology With AI To Personalize Cancer Treatment Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Panel Tue Oct 13 6:00pm–6:25pm Designing Prognostic & Predictive Biomarkers With Pathology: Implementation of AI in Diagnostics Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
European Institute of Oncology (IEO) Milan, Italy | |
Cancer research hospital in Milan providing oncology care, research and education. | Panel Wed Oct 14 8:05am–8:30am Artificial Intelligence In Pathology And Biomarker Testing Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Talk Wed Oct 14 9:10am–9:35am The Evolving Role Of Pathology In Precision Oncology Digital pathology & spatial biomarkers Panel Wed Oct 14 3:15pm–3:40pm Optimising Liquid Biopsy, MCED And MRD For Clinical Decision-Making Liquid biopsy & MRD |
Cancer research institute of Queen Mary University of London working on early detection, tumour biology and clinical trials. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access Talk Tue Oct 13 2:55pm–3:20pm A Translational Journey To Pancreatic Cancer Detection Biomarker discovery & translation |
Brunel University of London London, UK | |
Public research university in Uxbridge, west London. | Talk Tue Oct 13 12:15pm–12:40pm Enumeration And Characterisation Of Circulating Tumour Cells Using Imaging Flow Cytometry And Artificial Intelligence (AI) Liquid biopsy & MRDMultimodal & AI-enabled precision medicine Panel Wed Oct 14 8:05am–8:30am Quantum Computing For Biomarker Discovery Multimodal & AI-enabled precision medicineBiomarker discovery & translation |
Institute for Molecular Medicine Finland (FIMM) Helsinki, Finland | |
Research institute at the University of Helsinki working on human genomics, molecular medicine and precision medicine. | Panel Tue Oct 13 6:00pm–6:25pm Designing Prognostic & Predictive Biomarkers With Pathology: Implementation of AI in Diagnostics Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Talk Wed Oct 14 3:15pm–3:40pm Predictive AI Tools for Oncology Decision Support and Clinical Outcomes Multimodal & AI-enabled precision medicine |
Royal Brompton & Harefield Hospitals London, UK | |
Specialist heart and lung hospitals in London, part of Guy's and St Thomas' NHS Foundation Trust. | Talk Tue Oct 13 12:15pm–12:40pm Enumeration And Characterisation Of Circulating Tumour Cells Using Imaging Flow Cytometry And Artificial Intelligence (AI) Liquid biopsy & MRDMultimodal & AI-enabled precision medicine Panel Wed Oct 14 8:05am–8:30am Quantum Computing For Biomarker Discovery Multimodal & AI-enabled precision medicineBiomarker discovery & translation |
Uppsala University Uppsala, Sweden | |
Swedish research university whose work includes image analysis and AI for cancer screening. | Talk Tue Oct 13 5:10pm–5:35pm AI For Cervical Cancer Screening In A Global Setting Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Panel Tue Oct 13 6:00pm–6:25pm Designing Prognostic & Predictive Biomarkers With Pathology: Implementation of AI in Diagnostics Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Velindre University NHS Trust Cardiff, UK | |
Welsh NHS trust running the Velindre Cancer Service and the Welsh Blood Service. | Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation Talk Wed Oct 14 3:40pm–4:05pm Liquid Biopsy In Cancer Pathways - Welsh Perspective Liquid biopsy & MRD |
University of Exeter Exeter, UK | ○Network & Programme Sponsor |
UK university whose ISO 9001-certified research labs offer contract services to industry, including biomarker discovery, imaging and microbiology. | Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
Ashoka University Sonipat, India | |
Private liberal arts and sciences university near Delhi, India. | Talk Tue Oct 13 11:50am–12:15pm Gene Regulatory Network Inference In Health And Disease Genomics, proteomics and multi-omicsMultimodal & AI-enabled precision medicine |
Betsi Cadwaladr University Health Board Bangor, UK | |
NHS health board running hospital and community health services across North Wales. | Panel Tue Oct 13 12:40pm–1:30pm Overcoming Challenges In Deploying Foundation Models, LLMs And Agentic AI For Pathology Workflows Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers |
Centro di Riferimento Oncologico di Aviano Aviano, Italy | |
Public cancer research hospital in northeastern Italy combining oncology care and research. | Talk Tue Oct 13 5:10pm–5:35pm Diagnosing Classic Hodgkin Lymphoma in the Era of Artificial Intelligence Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers |
Erasmus MC Rotterdam, Netherlands | |
University medical centre in Rotterdam combining hospital care, research and medical education. | Talk Tue Oct 13 9:15am–9:40am The Molecular Evolution Of Glial Brain Tumors Genomics, proteomics and multi-omics |
Fraunhofer ITEM Hannover, Germany | |
Fraunhofer institute for toxicology and experimental medicine; its Regensburg division works on personalized tumor therapy, liquid biopsy and single-cell diagnostics. | Talk Tue Oct 13 5:10pm–5:35pm Exploring The Clinical Application Of Single Cell Analysis Genomics, proteomics and multi-omics |
Geneva University Hospitals (HUG) Geneva, Switzerland | |
Geneva's public university hospital group providing patient care, teaching and research. | Talk Tue Oct 13 5:35pm–6:00pm The Geneva University Hospitals Framework For Clinically Validating Digital Pathology Tools Digital pathology & spatial biomarkersClinical & companion diagnostic development |
Humanitas Research Hospital Rozzano, Italy | |
Research hospital near Milan combining clinical care, research and a medical university. | Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation |
Instantly find 20 buyers from universities, institutes and hospitals
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Biomarkers Europe 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction